Psychedelic: atai Life Sciences, NRx report quarterly results
PremiumThe FlyPsychedelic: atai Life Sciences, NRx report quarterly results
14d ago
Strategic Advancements and Financial Positioning Drive Buy Rating for NRX Pharmaceuticals
Premium
Ratings
Strategic Advancements and Financial Positioning Drive Buy Rating for NRX Pharmaceuticals
16d ago
NRx Pharmaceuticals Reports Progress in Drug Development and Strategic Expansion
Premium
Company Announcements
NRx Pharmaceuticals Reports Progress in Drug Development and Strategic Expansion
16d ago
NRx Pharmaceuticals invests $27M in subsidiary Hope for clinic acquisitions
PremiumThe FlyNRx Pharmaceuticals invests $27M in subsidiary Hope for clinic acquisitions
2M ago
NRx Pharmaceuticals announces $3.5M registered direct offering
Premium
The Fly
NRx Pharmaceuticals announces $3.5M registered direct offering
2M ago
NRX Pharmaceuticals Board Changes and Nasdaq Compliance
Premium
Company Announcements
NRX Pharmaceuticals Board Changes and Nasdaq Compliance
2M ago
HOPE Therapeutics announces planned acquisition of Dura Medical
PremiumThe FlyHOPE Therapeutics announces planned acquisition of Dura Medical
3M ago
NRx Pharmaceuticals, Hope announce planned acquisition of Kadima
Premium
The Fly
NRx Pharmaceuticals, Hope announce planned acquisition of Kadima
3M ago
NRx Pharmaceuticals announces first section of NDA for NRX-100
Premium
The Fly
NRx Pharmaceuticals announces first section of NDA for NRX-100
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100